Trial Profile
COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Apr 2022
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms COMBAT-MI
- 10 Apr 2022 Status changed from recruiting to completed.
- 21 Jul 2015 New trial record